Alumis Inc. (ALMS) Stock News & Chart | StockAdder

(ALMS)

Alumis Inc.

Stock chart and latest news for Alumis Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Alumis Inc. News

PRO

Quiver Quantitative

Alumis Inc. Stock (ALMS) Opinions on Phase 3 Trial Results

Jan 13, 2026 Yahoo Finance

Alumis (ALMS) Valuation Check After Strong Multi‑Month Share Price Momentum

Feb 7, 2026 MSN

Raymond James and Guggenheim stay bullish on Alumis (ALMS) after trial results

Apr 7, 2026 Stock Titan

A psoriasis pill hit late-stage goals; Alumis plans U.S. filing in 2026

Mar 19, 2026 Latham & Watkins LLP

Latham & Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock

Jan 9, 2026 simplywall.st

After losing 3.7% in the past year, Alumis Inc. (NASDAQ:ALMS) institutional owners must be relieved by the recent gain

Dec 5, 2025 Investing.com

Alumis Inc stock hits all-time high at 28.34 USD

Feb 19, 2026 TIKR.com

Why Alumis Stock Spiked Almost 100% Yesterday

Jan 7, 2026 Yahoo Finance

HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating

Jan 15, 2026 Quiver Quantitative

Alumis Inc. Stock (ALMS) Opinions on Insider Purchases and Clinical Updates | ALMS Stock News

Nov 20, 2025 Stock Titan

Alumis (ALMS) insider-linked entities shift 4.1M shares via in-kind distributions

Apr 3, 2026 Investing.com

Alumis stock soars after drug shows strong psoriasis results in Phase 3